Skip to main navigation
MENU
x
Investors + Newsroom
Culture + Careers
Who We Are
Who We Are
PIONEERS IN GENE THERAPY
MISSION & VALUES
MANAGEMENT TEAM
BOARD OF DIRECTORS
Science & Innovation
Science & Innovation
WHAT IS AAV GENE THERAPY?
NAV® TECHNOLOGY PLATFORM
PARTNERS & LICENSEES
MANUFACTURING
PUBLICATIONS
Therapeutic Pipeline
Therapeutic Pipeline
ABBV-RGX-314 FOR RETINAL DISEASES
RGX-202 FOR DUCHENNE
RGX-121 FOR MPSII (HUNTER SYNDROME)
Patients & Families
Patients & Families
WHY GENE THERAPY?
WET AMD
DUCHENNE
MPS II
EXPANDED ACCESS
Search
Investors + Newsroom
Culture + Careers
Biography
Overview
News
Events + Presentations
Stock Information
Analyst Coverage
Sec Filings
Corporate Governance
Shareholder Services
Brian Skorney, CFA
Robert W. Baird
Contact Us
Stay connected on REGENXBIO programs and our commitment to patients.
Contact Us
